These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 12513109)
1. Formoterol delivered by Turbuhaler: in pediatric asthma. Cheer SM; Warner GT; Easthope SE Paediatr Drugs; 2003; 5(1):63-8; discussion 69. PubMed ID: 12513109 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405 [TBL] [Abstract][Full Text] [Related]
3. The use of inhaled formoterol in the treatment of asthma. Berger WE Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777 [TBL] [Abstract][Full Text] [Related]
4. Formoterol: a review of its use in chronic obstructive pulmonary disease. Cheer SM; Scott LJ Am J Respir Med; 2002; 1(4):285-300. PubMed ID: 14720051 [TBL] [Abstract][Full Text] [Related]
5. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease. Prenner BM Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266 [TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I; Hall IP; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [TBL] [Abstract][Full Text] [Related]
7. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720 [TBL] [Abstract][Full Text] [Related]
8. Effects of treatment with formoterol on bronchoprotection against methacholine. Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025 [TBL] [Abstract][Full Text] [Related]
9. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Tötterman KJ; Huhti L; Sutinen E; Backman R; Pietinalho A; Falck M; Larsson P; Selroos O Eur Respir J; 1998 Sep; 12(3):573-9. PubMed ID: 9762782 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma. Bjermer L; Rosenborg J; Bengtsson T; Lötvall J Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol. Shapiro GS; Yegen U; Xiang J; Kottakis J; Della Cioppa G Clin Ther; 2002 Dec; 24(12):2077-87. PubMed ID: 12581546 [TBL] [Abstract][Full Text] [Related]
12. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma. Bensch G; Berger WE; Blokhin BM; Socolovsky AL; Thomson MH; Till MD; Castellsague J; Della Cioppa G; Ann Allergy Asthma Immunol; 2002 Aug; 89(2):180-90. PubMed ID: 12197575 [TBL] [Abstract][Full Text] [Related]
13. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137 [TBL] [Abstract][Full Text] [Related]
15. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127 [TBL] [Abstract][Full Text] [Related]
16. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study. Ekström T; Ringdal N; Tukiainen P; Runnerström E; Soliman S Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798 [TBL] [Abstract][Full Text] [Related]
17. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
18. Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators. van der Molen T; Sears MR; de Graaff CS; Postma DS; Meyboom-de Jong B Eur Respir J; 1998 Jul; 12(1):30-4. PubMed ID: 9701410 [TBL] [Abstract][Full Text] [Related]
19. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]